Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Mr. Stephen La Neve es el President de Accuray Inc, se unió a la empresa desde 2025.
¿Qué tal es el rendimiento del precio de la acción ARAY?
El precio actual de ARAY es de $0.392, ha aumentado un 1.52% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Accuray Inc?
Accuray Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Accuray Inc?
La capitalización bursátil actual de Accuray Inc es $46.5M
¿Es Accuray Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 4 analistas han realizado calificaciones de análisis para Accuray Inc, incluyendo 4 fuerte compra, 3 compra, 1 mantener, 0 venta, y 4 fuerte venta